Does periconceptional multivitamin use reduce the risk for limb deficiency in offspring?

Epidemiology

Volumn 8, Issue 2, 1997, Pages 157-161

  Yang, Quanhe ^a   Khoury, Muin J ^a   Olney, Richard S ^a   Mulinare, Joseph ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

case control study; limb deficiency; maternal exposure; multivitamins

Indexed keywords

MULTIVITAMIN;

ARTICLE; BIRTH DEFECT; CASE CONTROL STUDY; CONCEPTION; CONTROLLED STUDY; DRUG USE; HUMAN; INFANT; LIMB DEFECT; MAJOR CLINICAL STUDY; MOTHER CHILD RELATION; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0031049636     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199703000-00006     Document Type: Article

References (30)

1. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, Read AP, Fielding DW. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet 1980;1:339-340.
2. Smithells RW, Sheppard S, Wild J, Schorah CJ. Prevention of neural tube defects recurrences in Yorkshire: final report. Lancet 1989;2:498-499.
3. Mulinare J, Cordero J, Erickson JD, Berry RJ. Periconceptional use of multivitamin and the occurrence of neural tube defects. JAMA 1988;260: 3141-3145.
4. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defect: evidence from a case-control study in Western Australia. Med J Aust 1989;150:613-619.
5. Bower C, Stanley FJ. Periconceptional vitamin supplementation and neural-tube defect: evidence from a case-control study in Western Australia and a review of recent publications. J Epidemiol Community Health 1992;46:157-161.
6. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, Willett W. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-2852.
7. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 1993;306:1645-1648.
8. Laurence KM, James N, Miller MH, Tennant JB, Campbell H. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. BMJ 1981;282:1509-1511.
9. MRC Vitamin Study Research Group. Prevention of neural-tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338: 131-137.
10. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6:219-216.
11. Shaw GM, Wasserman CR, O'Malley CD. Periconceptional vitamin use and reduced risk for conotruncal and limb deficiency in California. Teratology 1994;49:372.
12. Li DK, Daling JR, Mueller BA, Hickok DE, Fantel AG, Weiss NS. Periconceptional multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 1995;6:212-218.
13. Erickson JD, Mulinare J, McClain PW, Fitch TG, James LM, McClearn AB, Adams MJ Jr. Vietnam veterans' risk for fathering babies with birth defects. JAMA 1984;252:903-912.
14. Erickson JD, Mulinare J, McClain PW, Fitch TG, James LM, McClearn AB, Adams MJ Jr. Vietnam Veterans' Risk for Fathering Babies with Birth Defects. Atlanta: Centers for Disease Control, 1984.
15. International Clearinghouse for Birth Defects Monitoring System. Limb Reduction Defects: Annual Report. Stockholm: Garnisonslryckeriet, 1984; 41-47.
16. Bartholomew DJ. A test of homogeneity for ordered alternatives. Biometrika 1959;46:36-48.
17. Lewis J, Martin P. Limbs: a pattern emerges. Nature 1989;342:734-735.
18. Hoyme HE, Jones KL, Dixon SD, Jewett T, Hanson JW, Robinson LK, Msall ME, Allanson JE. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 1990;85:743-746.
19. Gonzlez CH, Vargas FR, Pérez AB, Kim CA, Brunoni D, Marques-Dias MJ, Leone CR, Correa Neto J, Llerena Junior JC, de Almeida JC. Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy. Am J Med Genet 1993;47:59-64.
20. Centers for Disease Control and Prevention. Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling. MMWR Morbid Mortal Wkly Rep 1995;44(No. RR-9):1-12.
21. Holmes LB. Possible fetal effects of cervical dilation and uterine curettage during the first trimester of pregnancy. J Pediatr 1995;126:131-134.
22. Viljoen DL. Porencephaly and transverse limb defects following severe maternal trauma in early pregnancy. Clin Dysmorphol 1995;4:75-78.
23. Harmon JV, Osathanondh R, Holmes LB. Symmetrical terminal transverse limb defects: report of a twenty-week fetus. Teratology 1995;51:237-242.
24. Thersch JB. Therapeutic abortions with a folic acid antagonist, aminopteroylglutamic acid (4-amino PGA), administered by the oral route. Am J Obstet Gynecol 1952;63:1:298-304.
25. Milunsky A, Graet JW, Gaynor MF Jr. Methotrexate induced congenital malformations with a review of the literature. J Pediatr 1968;72:790-795.
26. Warkany J. Congenital malformation induced by maternal dietary deficiency: experiments and their interpretations. Harvey Lect 1952-1953;48: 89-109.
27. Nelson MM, Asling CW, Evans HM. Production of multiple congenital abnormalities in young by maternal pteroylglutamic acid deficiency during gestation. J Nutr 1952;48:61-80.
28. Warkany J. Disturbance of embryonic development by maternal vitamin deficiencies. J Cell Comp Physiol 1954;43(suppl):207-236.
29. Botto LD, Khoury MJ, Mulinare J, Erickson JD. Periconceptional multivitamin use and the occurrence of conotruncal heart defects: results from a population-based case-control study. Pediatrics 1996;98:911-917.
30. Khoury HJ, James LM, Erickson JD. On the use of affected controls to address recall bias in case-control studies of birth defects. Teratology 1994; 49:273-281.